Zheng Q, Lu C, Yu L, Zhan Y, Chen Z
Heliyon. 2024; 10(6):e27473.
PMID: 38509894
PMC: 10950590.
DOI: 10.1016/j.heliyon.2024.e27473.
Lee S, Kim T
Clin Mol Hepatol. 2023; 29(4):958-968.
PMID: 37822213
PMC: 10577334.
DOI: 10.3350/cmh.2023.0274.
Wu D, Xia M, Yan A, Jiang H, Fan J, Zhou S
Sci Rep. 2023; 13(1):11447.
PMID: 37454126
PMC: 10349838.
DOI: 10.1038/s41598-023-38577-w.
Xi D, Xu M, Han M, Guan Q, Guo Q, Yan F
J Hepatocell Carcinoma. 2023; 10:909-920.
PMID: 37346771
PMC: 10281284.
DOI: 10.2147/JHC.S412643.
Long M, Li J, He M, Qiu J, Zhang R, Liu Y
Radiat Oncol. 2023; 18(1):96.
PMID: 37287040
PMC: 10245442.
DOI: 10.1186/s13014-023-02292-7.
Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases.
Singh S, Roy R, Kumar S, Srivastava P, Jha S, Rana B
Cancers (Basel). 2023; 15(8).
PMID: 37190200
PMC: 10136566.
DOI: 10.3390/cancers15082272.
The impact of HIV infection on clinical presentation and mortality among persons with hepatocellular carcinoma in Kampala, Uganda.
Nsibirwa S, Aizire J, Mugerwa J, Thomas D, Ocama P, Kirk G
BMC Infect Dis. 2023; 23(1):216.
PMID: 37024807
PMC: 10080890.
DOI: 10.1186/s12879-023-08164-5.
Albumin-Globulin Score Combined with Skeletal Muscle Index as a Novel Prognostic Marker for Hepatocellular Carcinoma Patients Undergoing Liver Transplantation.
Huang Y, Wang N, Xu L, Wu Y, Li H, Jiang L
J Clin Med. 2023; 12(6).
PMID: 36983238
PMC: 10051871.
DOI: 10.3390/jcm12062237.
Mutational signatures representative transcriptomic perturbations in hepatocellular carcinoma.
Wu Q, Wang L, Tsui S
Front Genet. 2022; 13:970907.
PMID: 36081995
PMC: 9445436.
DOI: 10.3389/fgene.2022.970907.
Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells.
Tsunedomi R, Yoshimura K, Kimura Y, Nishiyama M, Fujiwara N, Matsukuma S
BMC Cancer. 2022; 22(1):260.
PMID: 35277124
PMC: 8917729.
DOI: 10.1186/s12885-022-09370-1.
Discoidin Domain Receptor 1, a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma.
Wu L, Zhao X, Ma H, Zhang L, Li X
Int J Gen Med. 2022; 15:2037-2044.
PMID: 35237068
PMC: 8882470.
DOI: 10.2147/IJGM.S348110.
Diagnostic timelines and self-reported symptoms of patients with lung and gastrointestinal cancers undergoing radiation therapy. Retrospective case control study.
Yannitsos D, Barbera L, Al-Rashdan A, Grendarova P
Support Care Cancer. 2021; 30(2):1501-1509.
PMID: 34533629
DOI: 10.1007/s00520-021-06522-0.
Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
Lin W, Xing K, Fu J, Ling Y, Li S, Yu W
JAMA Netw Open. 2021; 4(9):e2125055.
PMID: 34515782
PMC: 8438596.
DOI: 10.1001/jamanetworkopen.2021.25055.
Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
Wang R, Hu X, Liu X, Bai L, Gu J, Li Q
PLoS One. 2021; 16(4):e0249881.
PMID: 33861762
PMC: 8051809.
DOI: 10.1371/journal.pone.0249881.
Interactome analysis of gene expression profiles identifies CDC6 as a potential therapeutic target modified by miR-215-5p in hepatocellular carcinoma.
Xu H, Huang J, Hua S, Liang L, He X, Zhan M
Int J Med Sci. 2020; 17(18):2926-2940.
PMID: 33173413
PMC: 7646103.
DOI: 10.7150/ijms.51145.
Quantitative analysis of multiphase magnetic resonance images may assist prediction of histopathological grade of small hepatocellular carcinoma.
Weng S, Xu X, Li Y, Yan C, Chen J, Ye R
Ann Transl Med. 2020; 8(16):1023.
PMID: 32953823
PMC: 7475488.
DOI: 10.21037/atm-20-2874.
The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinoma.
Lin Y, Jin H, Wu X, Jian Z, Zou X, Huang J
Aging (Albany NY). 2020; 12(14):14391-14405.
PMID: 32716315
PMC: 7425490.
DOI: 10.18632/aging.103482.
CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma.
Yu Q, Gao K
Mol Med Rep. 2020; 22(3):2245-2252.
PMID: 32705212
PMC: 7411413.
DOI: 10.3892/mmr.2020.11336.
Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.
Wang L, Wang W, Rong W, Li Z, Wu F, Liu Y
BMC Cancer. 2020; 20(1):614.
PMID: 32611327
PMC: 7329435.
DOI: 10.1186/s12885-020-07087-7.
Prognostic Significance of Treatment Strategies for the Recurrent Hepatocellular Carcinomas After Radical Resection.
Saito R, Amemiya H, Hosomura N, Kawaida H, Maruyama S, Shimizu H
In Vivo. 2020; 34(3):1265-1270.
PMID: 32354917
PMC: 7279801.
DOI: 10.21873/invivo.11900.
